Dihydropyridine receptor of L-type Ca2+ channels: identification of binding domains for [3H](+)-PN200-110 and [3H]azidopine within the alpha 1 subunit.

No abstract is available for this paper.

• Publication year

  1991

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  1991-12-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1073/PNAS.88.23.10769PMID 1660150PMCID PMC53012
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Structure and function of voltage-gated sodium and calcium channels.

  1991cited by this paper
• Block of L-type calcium channels by charged dihydropyridines. Sensitivity to side of application and calcium

  1991cited by this paper
• Diazipine, a novel photoaffinity probe for dihydropyridine receptors of calcium channels

  1991cited by this paper
• 1990: annus mirabilis of potassium channels

  1991cited by this paper
• Identification of the site of interaction of the dihydropyridine channel blockers nitrendipine and azidopine with the calcium‐channel alpha 1 subunit.

  1991cited by this paper
• Identification of 1,4-dihydropyridine binding regions within the alpha 1 subunit of skeletal muscle Ca2+ channels by photoaffinity labeling with diazipine.

  1991cited by this paper
• Identification of a phenylalkylamine binding region within the alpha 1 subunit of skeletal muscle Ca2+ channels.

  1990cited by this paper
• Molecular properties of calcium channels.

  1990cited by this paper
• Pursuing the structure and function of voltage-gated channels.

  1990cited by this paper
• Classes of calcium channels in vertebrate cells.

  1989cited by this paper
• Influence of pHo on calcium channel block by amlodipine, a charged dihydropyridine compound. Implications for location of the dihydropyridine receptor

  1989cited by this paper
• Subunits of purified calcium channels: a 212-kDa form of alpha 1 and partial amino acid sequence of a phosphorylation site of an independent beta subunit.

  1989cited by this paper
• Molecular properties of dihydropyridine-sensitive calcium channels in skeletal muscle.

  1988cited by this paper
• Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa.

  1987cited by this paper
• The 165-kDa peptide of the purified skeletal muscle dihydropyridine receptor contains the known regulatory sites of the calcium channel.

  1987cited by this paper
• Primary structure of the receptor for calcium channel blockers from skeletal muscle

  1987cited by this paper
• Stereoselective photoaffinity labelling of the purified 1,4-dihydropyridine receptor of the voltage-dependent calcium channel.

  1986cited by this paper
• Characterization and photoaffinity labeling of receptor sites for the Ca2+ channel inhibitors d-cis-diltiazem, (+/-)-bepridil, desmethoxyverapamil, and (+)-PN 200-110 in skeletal muscle transverse tubule membranes.

  1986cited by this paper
• Subunit composition of skeletal muscle transverse tubule calcium channels evaluated with the 1,4‐dihydropyridine photoaffinity probe, [3H]azidopine.

  1985cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper

• Inhibition of CaV1.4 channels by CaV3 channel antagonists ML218 and Z944

  2025influential citation
• The molecular transition that confers voltage dependence to muscle contraction

  2025cites this paper
• Voltage gated sodium and calcium channels: Discovery, structure, function, and Pharmacology

  2023cites this paper
• Effect of Polyamidoamine-Dendrimer Nanoparticles Combined with Human Umbilical Vein Endothelial Cell Microenvironment on the Growth and Immune Infiltration of Nasopharyngeal Carcinoma Cell Line CNE-1

  2023cites this paper
• Structure and Pharmacology of Voltage-Gated Sodium and Calcium Channels.

  2020cites this paper
• Effects of selective calcium channel blockers on ions' permeation through the human Cav1.2 ion channel: A computational study.

  2020cites this paper
• Molecular Basis for Ligand Modulation of a Mammalian Voltage-Gated Ca2+ Channel.

  2019cites this paper
• Combination of Photoaffinity Label and Site-Directed Antibody for Target Proteins

  2017cites this paper
• Photoaffinity Labeling for Structural Probing Within Protein

  2017cites this paper
• Structural basis for inhibition of a voltage-gated Ca2+ channel by Ca2+ antagonist drugs

  2016cites this paper
• Drugging Undruggable Molecular Cancer Targets.

  2016cites this paper
• Calcium Channel CaVα₁ Splice Isoforms - Tissue Specificity and Drug Action.

  2015cites this paper
• Calcium Uptake Inhibition Activity

  2015cites this paper
• Structural Basis for Pharmacology of Voltage-Gated Sodium and Calcium Channels

  2015cites this paper
• Genetic disruption of voltage-gated calcium channels in psychiatric and neurological disorders

  2015cites this paper
• The Characterization of Nemadipine and Migrazole as Small Molecule Tools for Use in the Nematode Caenorhabditis elegans

  2013influential citation
• Effects of prototypic calcium channel blockers in methadone-maintained humans responding under a naloxone discrimination procedure.

  2013cites this paper
• Implicating the role of plasma membrane localized calcium channels and exchangers in stress-induced deleterious effects.

  2013cites this paper
• Increased intracellular magnesium attenuates β-adrenergic stimulation of the cardiac CaV1.2 channel

  2013cites this paper
• Una Contribución al Estudio de la Ca2 -ATPasa de Membrana Plasmática de Humanos y Proteínas Reguladoras de Calcio de Trypanosoma evansi.

  2013cites this paper
• Calcium channel block by Diltiazem

  2011cites this paper
• Mechanisms of p-Methoxycinnamic Acid-induced Increase in Insulin Secretion

  2011cites this paper
• Interaction of diltiazem with an intracellularly accessible binding site on CaV1.2

  2011cites this paper
• Mapping of dihydropyridine binding residues in a less sensitive invertebrate L-type calcium channel (LCav1)

  2011cites this paper
• Upregulation of the CaV 1.1-ryanodine receptor complex in a rat model of critical illness myopathy.

  2011cites this paper
• Structural Model for Phenylalkylamine Binding to L-type Calcium Channels*

  2009cites this paper
• L-Type Voltage-Dependent Calcium Channel Antagonists Impair Perirhinal Long-Term Recognition Memory and Plasticity Processes

  2009cites this paper
• Cardiovascular Activity

  2008cites this paper
• Channeling studies in yeast

  2007cites this paper
• Structural determinants of calcium channel subunit function

  2006cites this paper
• Towards selective antagonists of T-type calcium channels: design, characterization and potential applications of NNC 55-0396.

  2006cites this paper
• A dynamic α‐β inter‐subunit agonist signaling complex is a novel feedback mechanism for regulating L‐type Ca2+ channel opening

  2005cites this paper
• The L-type calcium channel alpha 1C subunit gene undergoes extensive, uncoordinated alternative splicing

  2005cites this paper
• Functional Architecture of the Inner Pore of a Voltage-gated Ca2+ Channel

  2005cites this paper
• Mini Review Molecular Basis of Permeation in Voltage-Gated Ion Channels

  2005cites this paper
• Human cardiac potassium channel DNA polymorphism modulates access to drug-binding site and causes drug resistance.

  2005cites this paper
• Functional interaction between local anaesthetics and calcium antagonists in guineapig myocardium : 2 . Electrophysiological studies with bupivacaine and nifedipinef

  2005cites this paper
• A dynamic alpha-beta inter-subunit agonist signaling complex is a novel feedback mechanism for regulating L-type Ca2+ channel opening.

  2005cites this paper
• Calcium Channels in the Heart

  2005cites this paper
• Biochemical Studies of Voltage-Gated Ca2+ Channels

  2005cites this paper
• Calcium Entry through L-Type Calcium Channels Is Essential for Neurite Regeneration in Cultured Sympathetic Neurons

  2004cites this paper
• Pharmacology of Cav1 (L-Type) Channels

  2004cites this paper
• Ion channels

  2004cites this paper
• Key Roles of Phe 1112 and Ser 1115 in the Pore-Forming IIIS5-S6 Linker of L-Type Ca 2 (cid:1) Channel (cid:1) 1C Subunit (Ca V 1.2) in Binding of Dihydropyridines and Action of Ca 2 (cid:1) Channel Agonists

  2003cites this paper
• Effects of three different L-type Ca2+ entry blockers on airway constriction induced by muscarinic receptor stimulation.

  2003cites this paper
• Ca * + channels : diversity of form and function

  2003cites this paper
• Key roles of Phe1112 and Ser1115 in the pore-forming IIIS5-S6 linker of L-type Ca2+ channel alpha1C subunit (CaV 1.2) in binding of dihydropyridines and action of Ca2+ channel agonists.

  2003cites this paper
• Molecular Pharmacology of High Voltage-Activated Calcium Channels

  2003cites this paper
• Sodium and Calcium Channel Blockers

  2002cites this paper
• Drug evolution: p-aminobenzoic acid as a building block.

  2002cites this paper
• A mutation in the β interaction domain of the Ca2+ channel α1C subunit reduces the affinity of the (+)‐[3H]isradipine binding site

  2002cites this paper
• Cardiac ion channels.

  2002cites this paper
• A mutation in the beta interaction domain of the Ca(2+) channel alpha(1C) subunit reduces the affinity of the (+)-[(3)H]isradipine binding site.

  2002cites this paper
• Sodium and Calcium Channel Blockers

  2002cites this paper
• Contraction of human colonic circular smooth muscle cells is inhibited by the calcium channel blocker pinaverium bromide.

  2001cites this paper
• Serine Residue in the IIIS5-S6 Linker of the L-type Ca2+ Channel α1C Subunit Is the Critical Determinant of the Action of Dihydropyridine Ca2+Channel Agonists*

  2000cites this paper
• Ca2+ channel antagonists and agonists

  2000cites this paper
• Molecular determinants of diltiazem block in domains IIIS6 and IVS6 of L-type Ca(2+) channels.

  2000cites this paper
• Distinctions in the molecular determinants of charged and neutral dihydropyridine block of L-type calcium channels.

  1999cites this paper
• Calcium channel blockers: current controversies and basic mechanisms of action.

  1999cites this paper
• Stereoselective characterization of the 1,4-dihydropyridine binding site at L-type calcium channels in the resting state and the opened/inactivated state.

  1999cites this paper
• L- and T-type calcium channel blockade - the efficacy of the calcium channel antagonist mibefradil

  1999cites this paper
• Lipophilic 4-isoxazolyl-1,4-dihydropyridines: synthesis and structure-activity relationships.

  1999cites this paper
• Photochemical localization of the semotiadil binding region within the cardiac Ca2+ channel α1 subunit. Comparison with the skeletal muscle counterpart

  1998cites this paper
• Isoform-specific inhibition of L-type calcium channels by dihydropyridines is independent of isoform-specific gating properties.

  1998cites this paper
• Photochemical Identification of Transmembrane Segment IVS6 as the Binding Region of Semotiadil, a New Modulator for the L-type Voltage-dependent Ca2+ Channel*

  1998cites this paper
• Molecular Basis of Drug Interaction with L-Type Ca2+ Channels

  1998cites this paper
• Conformational flexibility of voltage gated dihydropyridine sensitive calcium channel in hydrated DMPC bilayer.

  1998cites this paper
• Characteristics of L‐type calcium channel blockade by lacidipine in guinea‐pig ventricular myocytes

  1997cites this paper
• Regional Gradation of L‐Type Calcium Currents in the Feline Heart with a Healed Myocardial Infarct

  1997cites this paper
• Isolation and characterization of the primary structure of testis-specific L-type calcium channel: implications for contraception.

  1997cites this paper
• Transfer of the high affinity dihydropyridine sensitivity from L-type To non-L-type calcium channel.

  1997cites this paper
• Motif III S5 of L-type Calcium Channels Is Involved in the Dihydropyridine Binding Site

  1997cites this paper
• Analysis of the Dihydropyridine Receptor Site ofl-type Calcium Channels by Alanine-scanning Mutagenesis*

  1997cites this paper
• Major differences among the three classes of calcium antagonists.

  1997cites this paper
• Molecular Determinants of High Affinity Phenylalkylamine Block of l-type Calcium Channels in Transmembrane Segment IIIS6 and the Pore Region of the α1Subunit*

  1997cites this paper
• Molecular determinants of drug binding and action on L-type calcium channels.

  1997influential citation
• Pharmacological differences between calcium antagonists.

  1997cites this paper
• 1,5-benzothiazepine binding domain is located on the extracellular side of the cardiac L-type Ca2+ channel.

  1997cites this paper
• Molecular Studies on the Voltage Dependence of Dihydropyridine Action on L-type Ca2+ Channels

  1997cites this paper
• Construction of a high-affinity receptor site for dihydropyridine agonists and antagonists by single amino acid substitutions in a non-L-type Ca2+ channel.

  1997cites this paper
• Alternatively spliced IS6 segments of the alpha 1C gene determine the tissue-specific dihydropyridine sensitivity of cardiac and vascular smooth muscle L-type Ca2+ channels.

  1997cites this paper
• L-type calcium channels: binding domains for dihydropyridines and benzothiazepines are located in close proximity to each other.

  1997cites this paper
• Molecular pharmacology of UK-118, 434-05, a permanently charged amlodipine analog.

  1997cites this paper
• Nine L-type Amino Acid Residues Confer Full 1,4-Dihydropyridine Sensitivity to the Neuronal Calcium Channel α1ASubunit

  1997cites this paper
• Voltage‐dependent binding and calcium channel current inhibition by an anti‐α1D subunit antibody in rat dorsal root ganglion neurones and guinea‐pig myocytes

  1997cites this paper
• Calcium Channel Antagonists in Mood Disorders

  1997cites this paper
• Calcium Signaling Systems

  1997cites this paper
• Antagonist binding sites of voltage‐dependent calcium channels

  1997cites this paper
• The IVS6 segment of the L‐type calcium channel is critical for the action of dihydropyridines and phenylalkylamines.

  1996cites this paper
• Identification of binding sites for calcium channel antagonists.

  1996cites this paper
• Pharmakologische Grundlagen des zerebralen Calciumantagonismus

  1996cites this paper
• Ion Channels in Excitable Membranes

  1996cites this paper
• Molecular pharmacology of voltage-dependent calcium channels.

  1996cites this paper
• Structural and functional diversity of voltage-activated calcium channels.

  1996cites this paper
• Identification of Benz(othi)azepine-binding Regions within L-type Calcium Channel α1 Subunits*

  1996cites this paper
• Site of Covalent Labeling by a Photoreactive Batrachotoxin Derivative near Transmembrane Segment IS6 of the Sodium Channel Subunit (*)

  1996cites this paper
• Interaction of the L-Type Calcium Channel with Calcium Channel Blockers

  1996cites this paper
• Calcium channel antagonists in the treatment of coronary artery disease: fundamental pharmacological properties relevant to clinical use.

  1996cites this paper
• Altered Pharmacologic Responsiveness of Reduced L‐Type Calcium Currents in Myocytes Surviving in the Infarcted Heart

  1996cites this paper